Adrenocortical Carcinoma (ACC)
Adrenocortical Adenoma (ACA)
Pheochromocytoma (PHC)
Mixed Ampullary Carcinoma (MAMPCA)
Intestinal Ampullary Carcinoma (IAMPCA)
Ampullary Carcinoma (AMPCA)
Pancreatobiliary Ampullary Carcinoma (PAMPCA)
Adenosquamous Carcinoma of the Gallbladder (GBASC)
Gallbladder Adenocarcinoma, NOS (GBAD)
Extrahepatic Cholangiocarcinoma (EHCH)
Intrahepatic Cholangiocarcinoma (IHCH)
Small Cell Gallbladder Carcinoma (SCGBC)
Perihilar Cholangiocarcinoma (PHCH)
Gallbladder Cancer (GBC)
Cholangiocarcinoma (CHOL)
Bladder Adenocarcinoma (BLAD)
Bladder Squamous Cell Carcinoma (BLSC)
Mucosal Melanoma of the Urethra (URMM)
Urethral Adenocarcinoma (UAD)
Urethral Urothelial Carcinoma (UCU)
Bladder Urothelial Carcinoma (BLCA)
Inverted Urothelial Papilloma (IUP)
Inflammatory Myofibroblastic Bladder Tumor (IMTB)
Small Cell Bladder Cancer (SCBC)
Urethral Squamous Cell Carcinoma (USCC)
Upper Tract Urothelial Carcinoma (UTUC)
Plasmacytoid/Signet Ring Cell Bladder Carcinoma (SRCBC)
Urothelial Papilloma (UPA)
Urachal Adenocarcinoma (UA)
Sarcomatoid Carcinoma of the Urinary Bladder (SCB)
Urachal Carcinoma (URCA)
Urethral Cancer (UCA)
Mesenchymal Chondrosarcoma (MCHS)
Small Cell Osteosarcoma (SCOS)
Chondroblastic Osteosarcoma (CHOS)
Parosteal Osteosarcoma (PAOS)
Periosteal Osteosarcoma (PEOS)
High-Grade Surface Osteosarcoma (HGSOS)
Chondrosarcoma (CHS)
Dedifferentiated Chordoma (DDCHDM)
Myxoid Chondrosarcoma (MYCHS)
Osteoblastic Osteosarcoma (OSOS)
Chordoma (CHDM)
Fibroblastic Osteosarcoma (FIOS)
Ewing Sarcoma (ES)
Extraskeletal Myxoid Chondrosarcoma (EMCHS)
Osteosarcoma (OS)
Conventional Type Chordoma (CCHDM)
Low-Grade Central Osteosarcoma (LGCOS)
Chondroblastoma (CHBL)
Adamantinoma (ADMA)
Telangiectatic Osteosarcoma (TEOS)
Giant Cell Tumor of Bone (GCTB)
Dedifferentiated Chondrosarcoma (DDCHS)
Secondary Osteosarcoma (SECOS)
Mucinous Adenocarcinoma of the Colon and Rectum (MACR)
Tubular Adenoma of the Colon (TAC)
Colon Adenocarcinoma In Situ (CAIS)
High-Grade Neuroendocrine Carcinoma of the Colon and Rectum (HGNEC)
Goblet Cell Carcinoid of the Appendix (GCCAP)
Appendiceal Adenocarcinoma (APAD)
Anal Squamous Cell Carcinoma (ANSC)
Anorectal Mucosal Melanoma (ARMM)
Mucinous Adenocarcinoma of the Appendix (MAAP)
Medullary Carcinoma of the Colon (CMC)
Signet Ring Cell Type of the Appendix (SRAP)
Colon Adenocarcinoma (COAD)
Signet Ring Cell Adenocarcinoma of the Colon and Rectum (SRCCR)
Well-Differentiated Neuroendocrine Tumor of the Appendix (AWDNET)
Well-Differentiated Neuroendocrine Tumors of the Stomach (SWDNET)
Gastrointestinal Neuroendocrine Tumors (GINET)
Small Bowel Well-Differentiated Neuroendocrine Tumor (SBWDNET)
Small Bowel Cancer (SBC)
Colorectal Adenocarcinoma (COADREAD)
Well-Differentiated Neuroendocrine Tumor of the Rectum (RWDNET)
Colonic Type Adenocarcinoma of the Appendix (CTAAP)
Duodenal Adenocarcinoma (DA)
Rectal Adenocarcinoma (READ)
Anal Gland Adenocarcinoma (AGA)
Small Intestinal Carcinoma (SIC)
Fibroadenoma (FA)
Adenomyoepithelioma of the Breast (BRAME)
Breast Lobular Carcinoma In Situ (LCIS)
Borderline Phyllodes Tumor of the Breast (BLPT)
Breast Invasive Cancer, NOS (BRCANOS)
Juvenile Secretory Carcinoma of the Breast (JSCB)
Mixed Type Metaplastic Breast Cancer (MMBC)
Metaplastic Squamous Cell Carcinoma (MSCC)
Inflammatory Breast Cancer (IBC)
Phyllodes Tumor of the Breast (PT)
Metaplastic Breast Cancer (MBC)
Epithelial Type Metaplastic Breast Cancer (EMBC)
Breast Invasive Carcinoma, NOS (BRCNOS)
Breast Carcinoma with Signet Ring (BRSRCC)
Breast Invasive Carcinosarcoma, NOS (CSNOS)
Breast Fibroepithelial Neoplasms (BFN)
Breast Invasive Mixed Mucinous Carcinoma (IMMC)
Carcinoma with Chondroid Metaplasia (CCHM)
Breast Invasive Ductal Carcinoma (IDC)
Carcinoma with Osseous Metaplasia (COM)
Metaplastic Carcinosarcoma (MCS)
Benign Phyllodes Tumor of the Breast (BPT)
Paget Disease of the Nipple (PD)
Solid Papillary Carcinoma of the Breast (SPC)
Breast Angiosarcoma (BA)
Malignant Phyllodes Tumor of the Breast (MPT)
Breast Sarcoma (PBS)
Breast Neoplasm, NOS (BNNOS)
Breast Ductal Carcinoma In Situ (DCIS)
Breast Mixed Ductal and Lobular Carcinoma (MDLC)
Adenoid Cystic Breast Cancer (ACBC)
Invasive Breast Carcinoma (BRCA)
Breast Invasive Lobular Carcinoma (ILC)
Metaplastic Adenocarcinoma with Spindle Cell Differentiation (MASCC)
Metaplastic Adenosquamous Carcinoma (MASC)
Signet Ring Mucinous Carcinoma (SCEMU)
Mixed Cervical Carcinoma (MCCE)
Cervical Clear Cell Carcinoma (CECC)
Cervical Adenocarcinoma In Situ (CEAIS)
Cervical Squamous Cell Carcinoma (CESC)
Cervical Adenocarcinoma (CEAD)
Cervical Leiomyosarcoma (CELI)
Villoglandular Adenocarcinoma of the Cervix (VGCE)
Cervical Adenoid Basal Carcinoma (CABC)
Cervical Serous Carcinoma (CESE)
Cervical Rhabdomyosarcoma (CERMS)
Cervical Adenosquamous Carcinoma (CEAS)
Cervical Endometrioid Carcinoma (CEEN)
Mesonephric Carcinoma (CEMN)
Gastric Type Mucinous Carcinoma (GCEMU)
Small Cell Carcinoma of the Cervix (SCCE)
Cervical Neuroendocrine Tumor (CENE)
Villoglandular Carcinoma (CEVG)
Endocervical Adenocarcinoma (ECAD)
Cervical Adenoid Cystic Carcinoma (CACC)
Intestinal Type Mucinous Carcinoma (ICEMU)
Mucinous Carcinoma (CEMU)
Glassy Cell Carcinoma of the Cervix (CEGCC)
Dysembryoplastic Neuroepithelial Tumor (DNT)
Pineoblastoma (PBL)
Melanotic Medulloblastoma (MMBL)
Hemangiopericytoma of the Central Nervous System (HPCCNS)
Anaplastic Meningioma (ANM)
Dysplastic Gangliocytoma of the Cerebellum/Lhermitte-Duclos Disease (LDD)
Central Neurocytoma (CNC)
Hemangioblastoma (HMBL)
Pilocytic Astrocytoma (PAST)
Yolk Sac Tumor (BYST)
Rhabdoid Meningioma (RHM)
Meningioma (MNG)
Ependymoma (EPM)
Meningothelial Tumor (MNGT)
Medullomyoblastoma (MMB)
Angiocentric Glioma (ANGL)
Astrocytoma (ASTR)
Papillary Meningioma (PPM)
Atypical Teratoid/Rhabdoid Tumor (ATRT)
Pineal Parenchymal Tumor of Intermediate Differentiation (PPTID)
Choroid Plexus Papilloma (CPP)
Primitive Neuroectodermal Tumor (PNET)
Ependymomal Tumor (EPMT)
Primary Brain Tumor (PBT)
Papillary Tumor of the Pineal Region (PTPR)
Gangliocytoma (GNC)
Mesenchymal Chondrosarcoma of the CNS (MCHSCNS)
Atypical Choroid Plexus Papilloma (ACPP)
Anaplastic Ependymoma (APE)
Diffuse Astrocytoma (DASTR)
Mixed Germ Cell Tumor (BMGCT)
Malignant Tumor (MT)
Desmoplastic/Nodular Medulloblastoma (DMBL)
Choroid Plexus Tumor (CPT)
Miscellaneous Neuroepithelial Tumor (MNET)
Pleomorphic Xanthoastrocytoma (PXA)
Oligoastrocytoma (OAST)
Miscellaneous Brain Tumor (MBT)
Pituicytoma (PTCY)
Glioblastoma (GB)
Oligodendroglioma (ODG)
Papillary Glioneuronal Tumor (PGNT)
Cerebellar Liponeurocytoma (CLNC)
Medulloblastoma with Extensive Nodularity (MBEN)
Low-Grade Glioma, NOS (LGGNOS)
Low-Grade Neuroepithelial Tumor (LGNET)
Embryonal Tumor with Abundant Neuropil and True Rosettes (ETANTR)
Pituitary Adenoma (PTAD)
Craniopharyngioma, Adamantinomatous Type (ACPG)
High-Grade Glioma, NOS (HGGNOS)
Clear cell Meningioma (CCM)
Pineal Tumor (PINT)
Gliosarcoma (GSARC)
High-Grade Neuroepithelial Tumor (HGNET)
Pilomyxoid Astrocytoma (PMA)
Astroblastoma (ASTB)
Choroid Plexus Carcinoma (CPC)
Extraventricular Neurocytoma (EVN)
Anaplastic Oligoastrocytoma (AOAST)
Anaplastic Pleomorphic Xanthoastrocytoma (APXA)
Olfactory Neuroblastoma (ONBL)
Anaplastic Astrocytoma (AASTR)
Immature Teratoma (BIMT)
Atypical Meningioma (ATM)
Myxopapillary Ependymoma (MPE)
Anaplastic Ganglioglioma (AGNG)
Subependymoma (SUBE)
Glioblastoma Multiforme (GBM)
Atypical Pituitary Adenoma (APTAD)
Pituitary Carcinoma (PTCA)
Desmoplastic Infantile Astrocytoma (DIA)
Melanocytoma (MELC)
Glioma, NOS (GNOS)
Primary CNS Melanocytic Tumors (PCNSMT)
Spindle Cell Oncocytoma of the Adenohypophysis (SCOAH)
Chordoid Glioma of the Third Ventricle (CHGL)
Chordoid Meningioma (CHOM)
Craniopharyngioma, Papillary Type (PCGP)
Medulloepithelioma (MDEP)
Germ Cell Tumor, Brain (BGCT)
Malignant Lymphoma (MLYM)
Primary CNS Melanoma (PCNSM)
Pineocytoma (PINC)
Clear Cell Ependymoma (CCE)
Germinoma (GMN)
Diffuse Intrinsic Pontine Glioma (DIPG)
Rosette-forming Glioneuronal Tumor of the Fourth Ventricle (RGNT)
Diffuse Glioma (DIFG)
Primary Neuroepithelial Tumor (PRNET)
Small Cell Glioblastoma (SCGBM)
Sellar Tumor (SELT)
Ganglioglioma (GNG)
Large Cell/Anaplastic Medulloblastoma (AMBL)
Embryonal Carcinoma (BEC)
Embryonal Tumor (EMBT)
Malignant Teratoma (BMGT)
Solitary Fibrous Tumor of the Central Nervous System (SFTCNS)
Desmoplastic Infantile Ganglioglioma (DIG)
Choriocarcinoma (BCCA)
Granular Cell Tumor (GCT)
Anaplastic Oligodendroglioma (AODG)
Medulloblastoma (MBL)
Mature Teratoma (BMT)
Encapsulated Glioma (ENCG)
Small Cell Carcinoma of the Stomach (STSC)
Mucosal Melanoma of the Esophagus (ESMM)
Stomach Adenocarcinoma (STAD)
Intestinal Type Stomach Adenocarcinoma (ISTAD)
Poorly Differentiated Carcinoma of the Stomach (SPDAC)
Papillary Stomach Adenocarcinoma (PSTAD)
Esophageal Adenocarcinoma (ESCA)
Signet Ring Cell Carcinoma of the Stomach (SSRCC)
Tubular Stomach Adenocarcinoma (TSTAD)
Adenosquamous Carcinoma of the Stomach (STAS)
Gastric Remnant Adenocarcinoma (GRC)
Mucinous Stomach Adenocarcinoma (MSTAD)
Esophageal Poorly Differentiated Carcinoma (EPDCA)
Esophagogastric Adenocarcinoma (EGC)
Adenocarcinoma of the Gastroesophageal Junction (GEJ)
Smooth Muscle Neoplasm, NOS (SMN)
Esophageal Squamous Cell Carcinoma (ESCC)
Diffuse Type Stomach Adenocarcinoma (DSTAD)
Undifferentiated Stomach Adenocarcinoma (USTAD)
Uveal Melanoma (UM)
Ocular Melanoma (OM)
Conjunctival Melanoma (CM)
Retinoblastoma (RBL)
Salivary Duct Carcinoma (SDCA)
Head and Neck Squamous Cell Carcinoma (HNSC)
Odontogenic Carcinoma (ODGC)
Head and Neck Neuroendocrine Carcinoma (HNNE)
Myoepithelial Carcinoma (MYEC)
Mucoepidermoid Carcinoma (MUCC)
Parathyroid Cancer (PTH)
Salivary Carcinoma (SACA)
Oral Cavity Squamous Cell Carcinoma (OCSC)
Salivary Carcinoma, Other (OSACA)
Adenosquamous Carcinoma of the Tongue (ASCT)
Acinic Cell Carcinoma (ACCC)
Oropharynx Squamous Cell Carcinoma (OPHSC)
NUT Midline Carcinoma of the Head and Neck (NMCHN)
Sinonasal Adenocarcinoma (SNA)
Larynx Squamous Cell Carcinoma (LXSC)
Mammary Analogue Secretory Carcinoma of Salivary Gland Origin (HNMASC)
Salivary Gland Oncocytoma (SGO)
Hypopharynx Squamous Cell Carcinoma (HPHSC)
Sialoblastoma (SBL)
Epithelial-Myoepithelial Carcinoma (EMYOCA)
Head and Neck Mucosal Melanoma (HNMUCM)
Salivary Adenocarcinoma (SAAD)
Parathyroid Carcinoma (PTHC)
Sinonasal Undifferentiated Carcinoma (SNUC)
Adenoid Cystic Carcinoma (ACYC)
Head and Neck Carcinoma, Other (OHNCA)
Sinonasal Squamous Cell Carcinoma (SNSC)
Head and Neck Squamous Cell Carcinoma of Unknown Primary (HNSCUP)
Nasopharyngeal Carcinoma (NPC)
Clear Cell Odontogenic Carcinoma (CCOC)
FH-Deficient Renal Cell Carcinoma (FHRCC)
Translocation-Associated Renal Cell Carcinoma (TRCC)
Collecting Duct Renal Cell Carcinoma (CDRCC)
Renal Angiomyolipoma (RAML)
Renal Small Cell Carcinoma (RSCC)
Renal Clear Cell Carcinoma (CCRCC)
Renal Medullary Carcinoma (MRC)
Unclassified Renal Cell Carcinoma (URCC)
Renal Oncocytoma (ROCY)
Clear Cell Papillary Renal Cell Carcinoma (CCPRC)
Chromophobe Renal Cell Carcinoma (CHRCC)
Rhabdoid Cancer (MRT)
Sarcomatoid Renal Cell Carcinoma (SRCC)
Renal Cell Carcinoma (RCC)
Clear Cell Sarcoma of Kidney (CCSK)
Papillary Renal Cell Carcinoma (PRCC)
Renal Non-Clear Cell Carcinoma (NCCRCC)
Renal Clear Cell Carcinoma with Sarcomatoid Features (SCCRCC)
Wilms' Tumor (WT)
Renal Mucinous Tubular Spindle Cell Carcinoma (MTSCC)
Renal Neuroendocrine Tumor (RNET)
Undifferentiated Embryonal Sarcoma of the Liver (UESL)
Hepatoblastoma (LIHB)
Malignant Rhabdoid Tumor of the Liver (MRTL)
Liver Angiosarcoma (LIAS)
Fibrolamellar Carcinoma (FLC)
Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma (HCCIHCH)
Malignant Nonepithelial Tumor of the Liver (LIMNET)
Hepatocellular Adenoma (LIAD)
Hepatocellular Carcinoma (HCC)
Lung Carcinoid (LUCA)
Pleuropulmonary Blastoma (PPB)
Inflammatory Myofibroblastic Lung Tumor (IMTL)
Spindle Cell Carcinoma of the Lung (SPCC)
Adenoid Cystic Carcinoma of the Lung (LUACC)
Basaloid Large Cell Carcinoma of the Lung (BLCLC)
Lung Adenocarcinoma (LUAD)
Poorly Differentiated Non-Small Cell Lung Cancer (NSCLCPD)
Clear Cell Carcinoma of the Lung (CCLC)
Lung Squamous Cell Carcinoma (LUSC)
Pulmonary Lymphangiomyomatosis (LAM)
Small Cell Lung Cancer (SCLC)
Non-Small Cell Lung Cancer (NSCLC)
Combined Small Cell Lung Carcinoma (CSCLC)
Pleomorphic Carcinoma of the Lung (LUPC)
Giant Cell Carcinoma of the Lung (GCLC)
Lung Adenocarcinoma In Situ (LAIS)
Sarcomatoid Carcinoma of the Lung (SARCL)
Lung Neuroendocrine Tumor (LNET)
Salivary Gland-Type Tumor of the Lung (SGTTL)
Large Cell Lung Carcinoma (LCLC)
Atypical Lung Carcinoid (ALUCA)
Mucoepidermoid Carcinoma of the Lung (LUMEC)
Lung Adenosquamous Carcinoma (LUAS)
Lymphoepithelioma-like Carcinoma of the Lung (LECLC)
Large Cell Neuroendocrine Carcinoma (LUNE)
Large Cell Lung Carcinoma With Rhabdoid Phenotype (RLCLC)
Ciliated Muconodular Papillary Tumor of the Lung (CMPT)
T-Cell Large Granular Lymphocytic Leukemia (TLGL)
EBV Positive Mucocutaneous Ulcer (EBVMCU)
Florid Follicular Hyperplasia PTLD (FHPTLD)
Lymphocyte-Rich Classical Hodgkin Lymphoma (LRCHL)
Duodenal-Type Follicular Lymphoma (DFL)
High-Grade B-Cell Lymphoma, NOS (HGBCL)
Primary Cutaneous CD30 Positive T-Cell Lymphoproliferative Disorders (PCLPD)
Primary DLBCL of the central nervous system (PCNSL)
Indolent T-Cell Lymphoproliferative Disorder of the GI Tract (ITLPDGI)
Burkitt-Like Lymphoma with 11q Aberration (BLL11Q)
Mature T and NK Neoplasms (MTNN)
B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3);KMT2A Rearranged (BLLKMT2A)
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT lymphoma) (EMALT)
Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Gamma Heavy-Chain Disease (GHCD)
T-Lymphoblastic Leukemia/Lymphoma (TLL)
B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 (BLLETV6RUNX1)
ALK Positive Large B-Cell Lymphoma (ALKLBCL)
Angioimmunoblastic T-Cell Lymphoma (AITL)
Primary Cutaneous Anaplastic Large Cell Lymphoma (PCALCL)
T-Cell Prolymphocytic Leukemia (TPLL)
B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.3) IL3-IGH (BLLIL3IGH)
Nodal Peripheral T-Cell Lymphoma with TFH Phenotype (NPTLTFH)
Hepatosplenic T-cell Lymphoma (HSTCL)
B-Cell Prolymphocytic Leukemia (BPLL)
Amyloidosis (MIDDA)
Anaplastic Large-Cell Lymphoma ALK Positive (ALCLALKP)
Large B-Cell Lymphoma with IRF4 Rearrangement (LBLIRF4)
Splenic Diffuse Red Pulp Small B-Cell Lymphoma (SDRPL)
Infectious Mononucleosis PTLD (IMPTLD)
Nodular Sclerosis Classical Hodgkin Lymphoma (NSCHL)
IgA (MGUSIGA)
Primary Mediastinal (Thymic) Large B-Cell Lymphoma (PMBL)
Alpha Heavy-Chain Disease (AHCD)
Anaplastic Large-Cell Lymphoma ALK Negative (ALCLALKN)
B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1 Like (BLLBCRABL1L)
Marginal Zone Lymphoma (MZL)
Solitary Plasmacytoma of Bone (SPB)
Systemic EBV Positive T-Cell Lymphoma of Childhood (SEBVTLC)
Monoclonal Immunoglobulin Deposition Diseases, Other (MIDDO)
Mature B-Cell Neoplasms (MBN)
B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities (BLLRGA)
Lymphomatoid Granulomatosis (LYG)
Lymphoid Benign (LBGN)
EBV Positive DLBCL, NOS (EBVDLBCLNOS)
Mu Heavy-Chain Disease (MHCD)
Sezary Syndrome (SS)
Primary Cutaneous Acral CD8 Positive T-Cell Lymphoma (PCATCL)
Lymphoid Atypical (LATL)
Anaplastic Large Cell Lymphoma (ALCL)
Peripheral T-Cell lymphoma, NOS (PTCL)
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Monoclonal Immunoglobulin Deposition Diseases (MIDD)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLLSLL)
Extraosseous Plasmacytoma (EP)
Diffuse Large B-Cell Lymphoma, NOS (DLBCLNOS)
B-Lymphoblastic Leukemia/Lymphoma with iAMP21 (BLLIAMP21)
Follicular Lymphoma (FL)
Germinal Center B-Cell Type (GCB)
Breast Implant-Associated Anaplastic Large-Cell Lymphoma (BIALCL)
Primary Effusion Lymphoma (PEL)
Splenic Marginal Zone Lymphoma (SMZL)
Mantle Cell Lymphoma (MCL)
Hairy Cell Leukemia-Variant (HCL-V)
Lymphomatoid Papulosis (LYP)
Plasma Cell Myeloma (PCM)
Natural Killer (NK) Cell Lymphoblastic Leukemia/Lymphoma (NKCLL)
B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2);BCR-ABL1 (BLLBCRABL1)
Classical Hodgkin Lymphoma (CHL)
In Situ Mantle Cell Neoplasia (ISMCL)
Lymphoplasmacytic Lymphoma (LPL)
Burkitt Lymphoma (BL)
Primary Cutaneous Gamma Delta T-Cell Lymphoma (PCGDTCL)
Hydroa Vacciniforme Like Lymphoproliferative Disorder (HVLL)
Waldenstrom Macroglobulinemia (WM)
Activated B-cell Type (ABC)
B-Lymphoblastic Leukemia/Lymphoma (BLL)
IgM (MGUSIGM)
Mixed Cellularity Classical Hodgkin Lymphoma (MCCHL)
B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy (BLLHYPER)
Plasmablastic Lymphoma (PLBL)
Mycosis Fungoides (MYCF)
Nodal Marginal Zone Lymphoma (NMZL)
Splenic B-Cell Lymphoma/Leukemia, Unclassifiable (SBLU)
B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy (BLLHYPO)
IgG (MGUSIGG)
Primary Cutaneous Follicle Center Lymphoma (PCFCL)
Non-Hodgkin Lymphoma (NHL)
Plasmacytic Hyperplasia PTLD (PHPTLD)
Follicular T-Cell Lymphoma (FTCL)
Chronic Lymphoproliferative Disorder of NK Cells (CLPDNK)
DLBCL Associated with Chronic Inflammation (DLBCLCI)
Adult T-Cell Leukemia/Lymphoma (ATLL)
Intravascular Large B-Cell Lymphoma (IVBCL)
Posttransplant Lymphoproliferative Disorders (PTLD)
Aggressive NK-Cell Leukemia (ANKL)
Pediatric-Type Follicular Lymphoma (PTFL)
Primary Cutaneous CD8 Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma (PCAECTCL)
Hodgkin Lymphoma (HL)
Monomorphic PTLD (B- and T-/NK-cell types) (MPTLD)
Subcutaneous Panniculitis-Like T-Cell Lymphoma (SPTCL)
Early T-Cell Precursor Lymphoblastic Leukemia (ETPLL)
B-Lymphoblastic Leukemia/Lymphoma, NOS (BLLNOS)
Monoclonal B-Cell Lymphocytosis (MCBCL)
Primary Cutaneous CD4 Positive Small/Medium T-Cell Lymphoproliferative Disorder (PCSMTPLD)
Lymphoid Neoplasm (LNM)
T-Cell/Histiocyte-Rich Large B-Cell Lymphoma (THRLBCL)
Lymphocyte-Depleted Classical Hodgkin Lymphoma (LDCHL)
High-Grade B-Cell Lymphoma, with MYC and BCL2 and/or BCL6 Rearrangements (HGBCLMYCBCL2)
Extranodal NK-/T-Cell Lymphoma, Nasal Type (ENKL)
Primary Cutaneous DLBCL, Leg Type (PCLBCLLT)
B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3);TCF3-PBX1 (BLLTCF3PBX1)
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma (MEATL)
HHV8 Positive DLBCL, NOS (HHV8DLBCL)
Hairy Cell Leukemia (HCL)
Enteropathy-Associated T-Cell Lymphoma (EATL)
Polymorphic PTLD (PPTLD)
B-Cell Lymphoma, Unclassifiable, with Features Intermediate between DLBCL and Classical Hodgkin lymphoma (BCLU)
Classical Hodgkin Lymphoma PTLD (CHLPTLD)
In Situ Follicular Neoplasia (ISFN)
Histiocytic and Dendritic Cell Neoplasms (HDCN)
Primary Myelofibrosis (PMF)
AML with Minimal Differentiation (AMLMD)
AML without Maturation (AWM)
Acute Leukemias of Ambiguous Lineage (ALAL)
Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement (MLNPDGFRA)
Smoldering Systemic Mastocytosis (SSM)
Histiocytic Sarcoma (HS)
Interdigitating Dendritic Cell Sarcoma (IDCS)
Essential Thrombocythemia Myelofibrosis (ETMF)
Rosai-Dorfman Disease (RDD)
Indeterminate Dendritic Cell Tumor (IDCT)
Follicular Dendritic Cell Sarcoma (FDCS)
Myelodysplastic Syndromes (MDS)
AML with Myelodysplasia-Related Changes (AMLMRC)
Disseminated Juvenile Xanthogranuloma (JXG)
Therapy-Related Myeloid Neoplasms (TMN)
AML with Recurrent Genetic Abnormalities (AMLRGA)
AML, NOS (AMLNOS)
MDS/MPN with Ring Sideroblasts and Thrombocytosis (MDSMPNRST)
Langerhans Cell Sarcoma (LCS)
Systemic Mastocytosis with an Associated Hematological Neoplasm (SMAHN)
Aggressive Systemic Mastocytosis (ASM)
Myeloid Atypical (MATPL)
Myeloproliferative Neoplasms (MPN)
Transient Abnormal Myelopoiesis (TAM)
Myeloid Benign (MBGN)
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Mixed Phenotype Acute Leukemia with t(v;11q23.3); KMT2A Rearranged (MPALKMT2A)
MDS with Ring Sideroblasts (MDSRS)
Chronic Myelomonocytic Leukemia-1 (CMML1)
Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)
AML with t(9;11)(p21.3;q23.3);MLLT3-KMT2A (AMLMLLT3KMT2A)
Chronic Myelomonocytic Leukemia (CMML)
Langerhans Cell Histiocytosis (LCH)
Systemic Mastocytosis (SM)
MDS with Multilineage Dysplasia (MDSMD)
MDS with excess blasts-2 (MDSEB2)
AML with Mutated RUNX1 (AMLRUNX1)
MDS, Unclassifiable (MDSU)
Chronic Eosinophilic Leukemia, NOS (CELNOS)
Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2 (MLNER)
AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM (AMLGATA2MECOM)
Chronic Myeloid Leukemia, BCR-ABL1+ (CMLBCRABL1)
Acute Monoblastic/Monocytic Leukemia (AMOL)
Essential Thrombocythemia (ET)
Primary Myelofibrosis, Prefibrotic/Early Stage (PMFPES)
Polycythemia Vera (PV)
Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement (MLNPDGFRB)
MDS with excess blasts-1 (MDSEB1)
Myeloid Neoplasms with Germ Line Predisposition (MNGLP)
Mixed Phenotype Acute Leukemia, T/Myeloid, NOS (MPALTNOS)
Mixed Phenotype Acute Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 (MPALBCRABL1)
Erdheim-Chester Disease (ECD)
Mast Cell Sarcoma (MCSL)
AML with BCR-ABL1 (AMLBCRABL1)
Myeloid Leukemia Associated with Down Syndrome (MLADS)
Refractory Cytopenia of Childhood (RCYC)
Mast Cell Leukemia (SMMCL)
AML (megakaryoblastic) with t(1;22)(p13.3;q13.3);RBM15-MKL1 (AMLRBM15MKL1)
Mixed Phenotype Acute Leukemia, B/Myeloid, NOS (MPALBNOS)
Polycythaemia Vera Myelofibrosis (PVMF)
Atypical Chronic Myeloid Leukemia, BCR-ABL1- (ACML)
Myeloproliferative Neoplasms, Unclassifiable (MPNU)
APL with PML-RARA (APLPMLRARA)
Therapy-Related Acute Myeloid Leukemia (TAML)
Indolent Systemic Mastocytosis (ISM)
MDS with Ring Sideroblasts and Single Lineage Dysplasia (MDSRSSLD)
MDS with Isolated Del(5q) (MDSID5Q)
AML with t(6;9)(p23;q34.1);DEK-NUP214 (AMLDEKNUP214)
MDS with Excess Blasts (MDSEB)
MDS with Single Lineage Dysplasia (MDSSLD)
AML with Biallelic Mutations of CEBPA (AMLCEBPA)
Myeloid Neoplasm (MNM)
MDS with Ring Sideroblasts and Multilineage Dysplasia (MDSRSMD)
Juvenile Myelomonocytic Leukemia (JMML)
Acute Basophilic Leukemia (ABL)
Chronic Myelogenous Leukemia (CML)
Acute Undifferentiated Leukemia (AUL)
MDS/MPN, Unclassifiable (MDSMPNU)
Chronic Neutrophilic Leukemia (CNL)
Chronic Myelomonocytic Leukemia-0 (CMML0)
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement (MLNFGFR1)
Mastocytosis (MCD)
AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22);CBFB-MYH11 (AMLCBFBMYH11)
Acute Myeloid Leukemia (AML)
AML with Maturation (AM)
Myeloid Sarcoma (MS)
Therapy-Related Myelodysplastic Syndrome (TMDS)
AML with Mutated NPM1 (AMLNPM1)
Fibroblastic Reticular Cell Tumor (FRCT)
Primary Myelofibrosis,Overt Fibrotic Stage (PMFOFS)
Cutaneous Mastocytosis (CMCD)
Acute Myelomonocytic Leukemia (AMML)
Acute Megakaryoblastic Leukemia (AMKL)
Myeloid Proliferations Related to Down Syndrome (MPRDS)
Chronic Myelomonocytic Leukemia-2 (CMML2)
Acute Panmyelosis with Myelofibrosis (APMF)
Pure Erythroid Leukemia (PERL)
AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1 (AMLRUNX1RUNX1T1)
Myeloid/Lymphoid Neoplasms with PCM1-JAK2 (MLNPCM1JAK2)
Neuroendocrine Carcinoma, NOS (NECNOS)
Poorly Differentiated Carcinoma, NOS (PDC)
Small Cell Carcinoma of Unknown Primary (SCUP)
Adenocarcinoma, NOS (ADNOS)
Squamous Cell Carcinoma, NOS (SCCNOS)
Mixed Cancer Types (MIXED)
Acinar Cell Carcinoma, NOS (ACN)
Cancer of Unknown Primary, NOS (CUPNOS)
Neuroendocrine Tumor, NOS (NETNOS)
Cancer of Unknown Primary (CUP)
Undifferentiated Malignant Neoplasm (UDMN)
Extra Gonadal Germ Cell Tumor (EGCT)
Adenocarcinoma In Situ (AIS)
Mucinous Ovarian Cancer (MOV)
Steroid Cell Tumor, NOS (SCT)
Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor (OCS)
Gonadoblastoma (OGBL)
Ovarian Seromucinous Carcinoma (OSMCA)
Clear Cell Ovarian Cancer (CCOV)
High-Grade Serous Ovarian Cancer (HGSOC)
Ovarian Seromucinous Adenoma (OSMAD)
Mature Teratoma (OMT)
Serous Borderline Ovarian Tumor (SBOV)
Mixed Ovarian Carcinoma (MXOV)
High-Grade Neuroendocrine Carcinoma of the Ovary (HGONEC)
Ovarian Seromucinous Borderline Tumor (OSMBT)
Ovarian Epithelial Tumor (OVT)
Embryonal Carcinoma (OEC)
Small Cell Carcinoma of the Ovary (SCCO)
High-Grade Serous Fallopian Tube Cancer (HGSFT)
Yolk Sac Tumor (OYST)
Mixed Germ Cell Tumor (OMGCT)
Serous Ovarian Cancer (SOC)
Ovarian Choriocarcinoma, NOS (OCNOS)
Sex Cord Stromal Tumor (SCST)
Dysgerminoma (ODYS)
Brenner Tumor, Borderline (BTBOV)
Granulosa Cell Tumor (GRCT)
Sertoli-Leydig Cell Tumor (SLCT)
Endometrioid Ovarian Cancer (EOV)
Immature Teratoma (OIMT)
Ovarian Germ Cell Tumor (OGCT)
Clear Cell Borderline Ovarian Tumor (CCBOV)
Polyembryoma (OPE)
Brenner Tumor, Benign (BTBEOV)
Fibrothecoma (FT)
Brenner Tumor (BTOV)
Low-Grade Serous Ovarian Cancer (LGSOC)
Brenner Tumor, Malignant (BTMOV)
Serous Borderline Ovarian Tumor, Micropapillary (SBMOV)
Ovarian Cancer, Other (OOVC)
Endometrioid Borderlin Ovarian Tumor (EBOV)
Mucinous Borderline Ovarian Tumor (MBOV)
Pancreatic Neuroendocrine Tumor (PANET)
Pancreatic Adenocarcinoma (PAAD)
Osteoclastic Giant Cell Tumor (OSGCT)
Solid Pseudopapillary Neoplasm of the Pancreas (SPN)
Mucinous Cystic Neoplasm (MCN)
Acinar Cell Carcinoma of the Pancreas (PAAC)
Cystic Tumor of the Pancreas (PACT)
Undifferentiated Carcinoma of the Pancreas (UCP)
Adenosquamous Carcinoma of the Pancreas (PAASC)
Serous Cystadenoma of the Pancreas (PSC)
Pancreatoblastoma (PB)
Intraductal Papillary Mucinous Neoplasm (IPMN)
Verrucous Penile Squamous Cell Carcinoma (VPSCC)
Basaloid Penile Squamous Cell Carcinoma (BPSCC)
Penile Squamous Cell Carcinoma (PSCC)
Warty Penile Squamous Cell Carcinoma (WPSCC)
Nerve Sheath Tumor (NST)
Neurofibroma (NFIB)
Ganglioneuroblastoma (GNBL)
Malignant Peripheral Nerve Sheath Tumor (MPNST)
Ganglioneuroma (GN)
Melanotic Schwannoma (MSCHW)
Cellular Schwannoma (CSCHW)
Schwannoma (SCHW)
Neuroblastoma (NBL)
Peritoneal Serous Carcinoma (PSEC)
Peritoneal Mesothelioma (PEMESO)
Pleural Mesothelioma, Biphasic Type (PLBMESO)
Pleural Mesothelioma, Epithelioid Type (PLEMESO)
Pleural Mesothelioma, Sarcomatoid Type (PLSMESO)
Pleural Mesothelioma (PLMESO)
Prostate Small Cell Carcinoma (PRSCC)
Prostate Squamous Cell Carcinoma (PRSC)
Prostate Neuroendocrine Carcinoma (PRNE)
Prostate Adenocarcinoma (PRAD)
Desmoplastic Melanoma (DESM)
Porphyria Cutania Tarda (PCT)
Dermatofibroma (DF)
Congenital Nevus (SKCN)
Melanoma (MEL)
Atypical Nevus (AN)
Merkel Cell Carcinoma (MCC)
Spiroma/Spiradenoma (SPIR)
Poroma/Acrospiroma (PORO)
Acral Melanoma (ACRM)
Proliferating Pilar Cystic Tumor (PPCT)
Basal Cell Carcinoma (BCC)
Skin Adnexal Carcinoma (SKAC)
Sebaceous Carcinoma (SEBA)
Lentigo Maligna Melanoma (SKLMM)
Melanoma of Unknown Primary (MUP)
Desmoplastic Trichoepithelioma (DTE)
Spitzoid Melanoma (SPZM)
Sweat Gland Carcinoma/Apocrine Eccrine Carcinoma (AECA)
Microcystic Adnexal Carcinoma (MAC)
Sweat Gland Adenocarcinoma (SGAD)
Atypical Fibroxanthoma (AFX)
Porocarcinoma/Spiroadenocarcinoma (POCA)
Dermatofibrosarcoma Protuberans (DFSP)
Cutaneous Melanoma (SKCM)
Aggressive Digital Papillary Adenocarcinoma (ADPA)
Extramammary Paget Disease (EMPD)
Cutaneous Squamous Cell Carcinoma (CSCC)
Endocrine Mucin Producing Sweat Gland Carcinoma (EMPSGC)
Inflammatory Myofibroblastic Tumor (IMT)
Leiomyosarcoma (LMS)
Epithelioid Hemangioendothelioma (EHAE)
Myxoid/Round-Cell Liposarcoma (MRLS)
Malignant Glomus Tumor (MGST)
Ossifying Fibromyxoid Tumor (OFMT)
Proximal-Type Epithelioid Sarcoma (PTES)
Aggressive Angiomyxoma (AA)
Perivascular Epithelioid Cell Tumor (PECOMA)
Gastrointestinal Stromal Tumor (GIST)
Rhabdomyosarcoma (RMS)
Myofibroma (MF)
Spindle Cell Rhabdomyosarcoma (SCRMS)
Solitary Fibrous Tumor/Hemangiopericytoma (SFT)
Infantile Fibrosarcoma (IFS)
Dedifferentiated Liposarcoma (DDLS)
Pleomorphic Rhabdomyosarcoma (PLRMS)
Alveolar Rhabdomyosarcoma (ARMS)
Well-Differentiated Liposarcoma (WDLS)
Pseudomyogenic Hemangioendothelioma (PMHE)
Myxofibrosarcoma (MFS)
Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma (MFH)
Glomangiosarcoma (GS)
Pleomorphic Liposarcoma (PLLS)
Tenosynovial Giant Cell Tumor Diffuse Type (TGCT)
Ewing Sarcoma of Soft Tissue (ESST)
Sclerosing Epithelioid Fibrosarcoma (SEF)
Low-Grade Fibromyxoid Sarcoma (LGFMS)
Histiocytic Dendritic Cell Sarcoma (HDCS)
Desmoid/Aggressive Fibromatosis (DES)
Angiosarcoma (ANGS)
Fibrosarcoma (FIBS)
Spindle Cell/Sclerosing Rhabdomyosarcoma (SCSRMS)
Soft Tissue Myoepithelial Carcinoma (STMYEC)
Desmoplastic Small-Round-Cell Tumor (DSRCT)
Myopericytoma (MPC)
Dendritic Cell Sarcoma (DCS)
Embryonal Rhabdomyosarcoma (ERMS)
Myofibromatosis (IMS)
Intimal Sarcoma (INTS)
Hemangioma (HEMA)
Paraganglioma (PGNG)
Myxoma (MYXO)
Clear Cell Sarcoma (CCS)
Radiation-Associated Sarcoma (RAS)
Synovial Sarcoma (SYNS)
Round Cell Sarcoma, NOS (RCSNOS)
Liposarcoma (LIPO)
Sarcoma, NOS (SARCNOS)
Alveolar Soft Part Sarcoma (ASPS)
Epithelioid Sarcoma (EPIS)
Angiomatoid Fibrous Histiocytoma (AFH)
Non-Seminomatous Germ Cell Tumor (NSGCT)
Testicular Lymphoma (TLYM)
Mixed Germ Cell Tumor (MGCT)
Seminoma (SEM)
Testicular Mesothelioma (TMESO)
Teratoma with Malignant Transformation (TMT)
Yolk Sac Tumor (TYST)
Sex Cord Stromal Tumor (TSCST)
Teratoma (TT)
Choriocarcinoma (TCCA)
Embryonal Carcinoma (EMBCA)
Thymic Epithelial Tumor (TET)
Thymoma (THYM)
Thymic Carcinoma (THYC)
Thymic Neuroendocrine Tumor (TNET)
Oncocytic Adenoma of the Thyroid (OAT)
Papillary Thyroid Cancer (THPA)
Hurthle Cell Thyroid Cancer (THHC)
Medullary Thyroid Cancer (THME)
Poorly Differentiated Thyroid Cancer (THPD)
Hyalinizing Trabecular Adenoma of the Thyroid (HTAT)
Anaplastic Thyroid Cancer (THAP)
Well-Differentiated Thyroid Cancer (WDTC)
Follicular Thyroid Cancer (THFO)
Low-Grade Endometrial Stromal Sarcoma (LGESS)
Uterine Leiomyosarcoma (ULMS)
Uterine Sarcoma/Mesenchymal (USARC)
Undifferentiated Uterine Sarcoma (UUS)
Other Uterine Tumor (OUTT)
Molar Pregnancy (MP)
Uterine Undifferentiated Carcinoma (UUC)
Uterine Adenosarcoma (UAS)
Uterine Mixed Endometrial Carcinoma (UMEC)
Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor (UCS)
Partial Hydatidiform Mole (PHM)
Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (USTUMP)
Choriocarcinoma (UCCA)
Uterine Dedifferentiated Carcinoma (UDDC)
Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma (USC)
Poorly Differentiated Carcinoma of the Uterus (UPDC)
Endometrial Carcinoma (UCEC)
Uterine Adenosquamous Carcinoma (UASC)
Uterine Neuroendocrine Carcinoma (UNEC)
Uterine Smooth Muscle Tumor (USMT)
Uterine Sarcoma, Other (OUSARC)
Uterine Leiomyoma (ULM)
Uterine Epithelioid Leiomyosarcoma (UELMS)
Uterine Perivascular Epithelioid Cell Tumor (UPECOMA)
Endometrial Stromal Sarcoma (ESS)
Epithelioid Trophoblastic Tumor (ETT)
Uterine Myxoid Leiomyosarcoma (UMLMS)
Gestational Trophoblastic Disease (GTD)
Uterine Mesonephric Carcinoma (UMNC)
Complete Hydatidiform Mole (CHM)
Uterine Endometrioid Carcinoma (UEC)
Placental Site Trophoblastic Tumor (PSTT)
Uterine Mucinous Carcinoma (UMC)
Uterine Clear Cell Carcinoma (UCCC)
High-Grade Endometrial Stromal Sarcoma (HGESS)
Invasive Hydatidiform Mole (IHM)
Yolk Sac Tumor (VYST)
Germ Cell Tumor of the Vulva (VGCT)
Polyembryoma (VPE)
Dysgerminoma (VDYS)
Squamous Cell Carcinoma of the Vulva/Vagina (VSC)
Mixed Germ Cell Tumor (VMGCT)
Embryonal Carcinoma (VOEC)
Immature Teratoma (VIMT)
Poorly Differentiated Vaginal Carcinoma (VPDC)
Mucinous Adenocarcinoma of the Vulva/Vagina (VMA)
Mature Teratoma (VMT)
Vaginal Adenocarcinoma (VA)
Mucosal Melanoma of the Vulva/Vagina (VMM)